Exclusive: Cell therapy CDMO Kincell launches, and the spinout is valued at $66M, with CEO looking for carve-outs
A small CDMO called Kincell Bio launched Wednesday, with its CEO hoping to fill a niche offering cell therapy manufacturing for early-stage biotech startups.
Kincell is a spinout of a Gainesville, FL-based manufacturing plant of Inceptor Bio, a North Carolina cell therapy biotech founded in 2020. It’s raised $36 million in a Series A financing led by Kineticos Ventures, which values the startup at $66 million, a source familiar with the matter told Endpoints News.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.